ディメチルフーマレートは病理的血管新生の阻害剤である
Pei Qin Ng1, Kelvin Huang2, Fergus C McLellan2
1Department of Plant Sciences, University of Cambridge, Downing Street, Cambridge CB2 3EA, Cambridgeshire, UK.
Cellular signalling
|September 4, 2025
まとめ
ダイメチルフーマレート (DMFu) は,新血管性老化性黄斑変性 (nAMD) の経口療法としての可能性を示しています. この薬は,内皮細胞機能とエネルギー代謝に影響を与えることで,目の病的な血管の成長を阻害します.
科学分野:
- 眼科について
- 分子生物学
- 薬物の再利用
背景:
- 血管内皮成長因子 (VEGF) は,新血管性年齢関連性黄斑変性 (nAMD) のような盲目性眼疾患の病理的な新血管化を引き起こします.
- ディメチルフーマレート (DMFu) は,FDAが承認した薬であり,nAMDにおける網膜の色素上皮の損傷に関連した抗炎症性を持っています.
研究 の 目的:
- ディメチルフーマレート (DMFu) の冠状腺および網膜内皮細胞に対する抗血管新生効果を調査する.
- nAMDの文脈でDMFuの抗血管新生の可能性を明らかにする分子メカニズム.
主な方法:
- ネズミの内皮細胞の増殖を評価する 桃体発芽試験
- 人間の微血管網膜内皮細胞 (HREC) を用いて細胞移動とチューブ形成を評価する試験.
- 大量RNA配列化,加重遺伝子共表現ネットワーク分析,遺伝子セット濃縮分析により,転写の変化を特定する.
- ミトコンドリア呼吸検査とウェスタン・ブロッティングで 代謝とタンパク質の変化を評価する
主要な成果:
- DMFuは,大腸内皮細胞の増殖を有意に抑制した.
- DMFuは,HRECにおけるVEGF誘発の細胞移動とチューブ形成を妨害した.
- DMFuは血管形態形成に関与する遺伝子を低下させ,マイクロチューブル輸送とATP合成に関連する経路を変化させた.
- DMFuはミトコンドリアの呼吸とSDHBタンパク質の発現を低下させ,同時に糖分分解を増加させた.
結論:
- DMFuは,nAMDに関連した有意な抗血管新生特性を示しています.
- DMFuのメカニズムは,内皮細胞の代謝と遺伝子発現を調節する.
- DMFuは,その有効性と患者フレンドリーな投与により,nAMDの口腔療法再利用の有望な候補である.
さらに関連する動画
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.3K
関連する概念動画
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
01:10Mechanism of Angiogenesis
5.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264